A new retrospective study from Greek researchers, published in the Archives of Dermatological Research, tackles precisely that question by measuring relapse kinetics, the speed and pattern with which actinic keratoses return after treatment. The team, led by Despina Exadaktylou and Ioannis D. Bassukas with colleagues in Athens and Ioannina, compared three real-world regimens used on the head: cryosurgery alone, cryosurgery followed by daylight photodynamic therapy, and cryosurgery followed by four weeks of topical imiquimod, an immune-response modifier applied as a cream. Their central finding is striking. The combination of mild freezing followed by a month of imiquimod produced a therapeutic effect lasting on average about fourteen months, significantly longer than either cryosurgery alone or cryosurgery paired with daylight photodynamic therapy, both of which delivered roughly eight to eight and a half months of benefit before relapse set in.

The study owes its unusual design to an unexpected legacy of the COVID-19 pandemic. During lockdowns, routine dermatology follow-ups across Greece and much of Europe were postponed, sometimes for many months or even years. For patients treated for field cancerization before the pandemic, that disruption meant the interval between treatment and the first post-treatment skin examination stretched far beyond the usual clinical schedule. Rather than discarding these irregular records, the researchers recognized them as a natural experiment: a dataset in which follow-up times varied enormously, from as little as twenty-eight days to as long as 1,379 days after the cryosurgery session that began each treatment cycle. That variation, normally a nuisance in clinical research, allowed them to trace how disease burden evolved across a much wider window of time than a conventional fixed-schedule study could capture.

The analysis included 116 treatment cycles involving head-located field cancerization regions in 30 patients, 27 of them men, with a median age of 81 years. The treated areas comprised 83 scalp regions, 26 forehead regions, and 7 cheek regions. Forty cycles were treated with cryosurgery monotherapy, 27 with the combination of cryosurgery and daylight photodynamic therapy, and 49 with cryosurgery plus imiquimod. To quantify disease burden, the team used a modified version of the Actinic Keratosis Area and Severity Index, known as AKASI, restricted to the treated head subregions. By scoring the same anatomical area before treatment and again at the first follow-up visit, they could calculate a change-from-baseline that reflected how much the treatment had actually improved the field, and how much of that improvement had eroded by the time the patient returned.

The statistical machinery behind the study combined nonparametric comparisons with survival analysis, a technique more familiar from oncology trials tracking time to tumor recurrence. Wilcoxon and Kruskal-Wallis tests assessed differences in continuous measures such as AKASI scores, while Kaplan-Meier curves and Cox proportional hazards methods modeled the time until relapse, defined through the first post-treatment evaluation for each therapy cycle. Significance was set at a two-tailed probability level below 0.05. This survival-style framing is what makes the study’s headline numbers meaningful: instead of simply asking whether patients improved, the researchers asked how long the improvement endured, treating the disappearance of the therapeutic effect as an event that could be timed and compared across the three treatment arms.

The results tell a nuanced story. Immediately after treatment, only the two combination modalities produced a statistically significant improvement in the field: the reductions in AKASI scores were significant for cryosurgery plus daylight photodynamic therapy and for cryosurgery plus imiquimod, while cryosurgery alone did not reach significance for initial field improvement. More importantly, that early advantage faded as follow-up time lengthened, a pattern the authors describe as the initial improvement vanishing with increasing time to first evaluation. In other words, the visible benefit of field treatment is real but transient, and the longer one waits before examining the skin, the less distinguishable the treated field becomes from its pretreatment state. This modality-independent erosion of benefit underscores why time-to-relapse, rather than short-term clearance rates, should be the metric that guides treatment planning.

When the duration of the therapeutic effect was compared directly, the differences between regimens became clear. Cryosurgery monotherapy yielded a mean effect duration of 8.34 months, with a 95 percent confidence interval spanning 5.21 to 11.48 months. Cryosurgery combined with daylight photodynamic therapy performed almost identically, at 8.53 months with a confidence interval of 4.16 to 12.90 months. Cryosurgery followed by four weeks of imiquimod, by contrast, extended the mean effect duration to 14.15 months, with a confidence interval of 9.94 to 18.37 months. Both combination regimens were significantly superior to cryosurgery alone, but the imiquimod combination was also significantly superior to the photodynamic therapy combination, with the Kaplan-Meier analysis yielding p values of 0.007 and 0.032 for the respective comparisons. For elderly patients, many of whom face repeated treatment cycles over decades, an extra five to six months of clearance per cycle is a clinically meaningful gain.

The biological logic behind this result is consistent with what is known about how these therapies work. Cryosurgery physically destroys visible lesions but does little to address the microscopic field of mutated cells surrounding them. Daylight photodynamic therapy uses a topical prodrug, methyl aminolevulinate, which is converted into a photosensitizer inside abnormal cells; exposure to daylight then triggers reactive oxygen species that kill those cells, with the advantage of being nearly painless compared with conventional artificial-light photodynamic therapy. Imiquimod takes a different route entirely: it activates toll-like receptor 7 on immune cells, unleashing a localized innate and adaptive immune response that targets genetically damaged keratinocytes over the weeks the cream is applied. The longer relapse time observed with the immunocryosurgery approach suggests that recruiting the patient’s own immune system to patrol the treated field provides a more durable suppression of residual disease than a single photodynamic insult, even when both are anchored by the same cryosurgery session.

The authors are candid about the limitations of their work. The study is retrospective, relies on chart review, involves a small number of patients and treatment cycles, and draws all of its data from a single clinical setting. The wildly variable follow-up times, while analytically exploitable, also mean that the relapse estimates depend on the assumption that a single post-treatment evaluation can represent the state of the field at that moment. The patient population, overwhelmingly elderly men with scalp disease, may not generalize to other groups. Still, the study was conducted under institutional ethical approval and in accordance with the Helsinki Declaration, and the authors report no funding and no competing interests. As a first quantitative map of relapse kinetics after field treatment with adjuvant cryosurgery, it offers something the field has lacked: a timeline. If confirmed in larger, prospective studies, the message for clinicians managing cutaneous field cancerization could be simple and consequential, namely that when the goal is to keep sun-damaged skin clear for as long as possible, a month of immune activation after freezing may be worth more than a day in the sun.

Subject of Research: Relapse kinetics of actinic keratoses after field treatments combining cryosurgery with daylight photodynamic therapy or topical imiquimod

Article Title: Relapse kinetics of actinic keratoses after field treatments with adjuvant cryosurgery: a retrospective study of cases with variable follow-up times

Article References: Exadaktylou, D., Chroni, P., Stefaniotou, S., Spyridonos, P., Gaitanis, G., & Bassukas, I. D. (2026). Relapse kinetics of actinic keratoses after field treatments with adjuvant cryosurgery: a retrospective study of cases with variable follow-up times. Archives of Dermatological Research, 318(1), Article 443. https://doi.org/10.1007/s00403-026-04931-x

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04931-x

Keywords: actinic keratosis, cutaneous field cancerization, cryosurgery, imiquimod, daylight photodynamic therapy, relapse kinetics, AKASI score, Kaplan-Meier analysis, skin cancer prevention, retrospective study, COVID-19 pandemic, dermatology

The study draws on the 2024 National Health Interview Survey, or NHIS, a large, nationally representative household survey conducted by the National Centers for Health Statistics at the Centers for Disease Control and Prevention. The NHIS is one of the workhorses of American public health surveillance, interviewing tens of thousands of households each year and covering topics that range from chronic disease to health insurance coverage. In its 2024 iteration, the survey included questions about sunburn and, critically, about the specific contexts in which sunburn occurred, allowing respondents who reported being burned in the past year to indicate the activities and settings associated with the burn. That contextual detail is what makes the new analysis possible, because a sunburn acquired during an afternoon of intentional sunbathing is a very different public health target than one acquired during an hour of outdoor occupational labor.

This distinction matters more than it might first appear. Behavioral counseling for skin cancer prevention, as evaluated in systematic reviews for the U.S. Preventive Services Task Force, has shown modest but meaningful effects, and randomized trials of sun protection advice, appearance-focused interventions, and skin self-examination programs have demonstrated that tailored messaging can shift behavior in durable ways. A ten-year follow-up of a randomized primary care study found that individualized sun protection advice produced sustainable changes in behavior. But tailoring requires knowing who is being burned where. A generic public health message about wearing sunscreen at the beach will do little for a construction worker who burns on the job and has never set foot on sand during the entire incident. Context-specific surveillance is therefore the foundation on which targeted prevention is built.

The companion analysis published by researchers at the CDC in MMWR, which reported the overall prevalence and context of sunburn among U.S. adults in 2024, established the headline numbers and the distribution of burn contexts across the general population. The new research letter by Schneiderman and Hartman extends that picture by stratifying sunburn contexts by sociodemographic characteristics, examining how age, sex, race and ethnicity, and other social variables pattern the settings in which burns occur. The analytic approach is conceptually straightforward but methodologically important: rather than treating all sunburns as equivalent events, the authors condition on adults who reported a sunburn and then examine the probability that the burn occurred in particular contexts, such as intentional outdoor recreation, unintentional exposure during routine activity, or occupational settings, across demographic strata.

The sociodemographic lens is essential because sunburn is not distributed randomly across the American population, and neither is the biology that translates ultraviolet exposure into cancer risk. Skin pigmentation, determined largely by the type and distribution of melanin in the epidermis, provides varying degrees of natural protection against ultraviolet radiation, and the interplay between constitutive pigmentation and behavioral exposure patterns produces complex epidemiology. Darker-skinned individuals can and do experience sunburn, and skin cancer in populations with skin of color is frequently diagnosed at later stages with worse outcomes, partly because both patients and clinicians underestimate the risk. At the same time, lighter-skinned individuals face higher baseline susceptibility, meaning that identical exposure doses produce different biological consequences in different people. Any prevention strategy that ignores this heterogeneity will misallocate its resources.

Occupational context adds another layer of complexity. Outdoor workers, including those in construction, agriculture, landscaping, and delivery services, accumulate substantial ultraviolet doses during working hours, often with limited control over their exposure and limited access to shade, protective clothing, or the time needed to reapply sunscreen. For these individuals, sunburn is not a leisure-time accident but a workplace hazard, and effective prevention may require employer-level interventions, labor policy, and engineering controls such as shade structures rather than individual behavioral advice alone. Distinguishing occupational burns from recreational burns in national surveillance data allows researchers and policymakers to see this distinction clearly and to design interventions appropriate to each setting.

Age and generational patterns are equally revealing. Younger adults have historically reported higher sunburn prevalence, consistent with greater participation in outdoor recreation and, in some cohorts, with deliberate tanning behavior, while older adults may burn during gardening, walking, or other incidental activities. Sex differences have also been documented in prior surveillance, with patterns that likely reflect both occupational composition and recreational behavior. By mapping these patterns within specific burn contexts, the new analysis provides the kind of detail that intervention scientists need: if young adults are disproportionately burned during intentional recreational sun exposure, appearance-focused and social-norm-based interventions, which have shown efficacy in randomized trials, may be the right tool; if middle-aged and older adults are burned during incidental and occupational exposure, structural and environmental approaches become more relevant.

The study also reflects a broader shift in how dermatological epidemiology is conducted. Rather than relying on small clinic-based samples or regional surveys, researchers increasingly leverage national surveillance instruments like the NHIS, which are publicly available, methodologically documented, and large enough to support subgroup analyses that would be underpowered in smaller datasets. The authors note that the underlying data are freely accessible through the CDC’s NHIS documentation portal, and the analysis required no institutional review board approval because it used deidentified data. This transparency and accessibility lower the barrier for replication and extension, allowing other investigators to test whether the patterns hold in subsequent survey years or to examine additional contextual variables as the survey evolves.

The clinical and public health implications are concrete. Sunburn is, in a meaningful sense, a sentinel event: it marks a failure of sun protection behavior or of environmental safeguards, and it is one of the few cancer risk exposures that individuals can observe in real time. The U.S. Preventive Services Task Force has recognized behavioral counseling for sun protection as an intervention with evidence of benefit, particularly in younger patients with lighter skin, and studies such as the Skin Awareness Trial have shown that even brief video-based interventions can increase skin self-examination among older men, a group at elevated melanoma risk. Surveillance that identifies precisely which demographic groups are burning in which contexts converts these general findings into actionable targeting, telling clinicians and public health programs who to reach, through which channels, and with which messages.

What emerges from the analysis is a portrait of sunburn in America that is far more textured than a single prevalence figure can convey. Behind every burned shoulder is a context, a beach day or a roofing job or an unplanned hour in the sun, and behind every context is a demographic profile that determines who is most likely to inhabit it. Schneiderman and Hartman’s work demonstrates that these profiles differ systematically, and that the differences are large enough to matter for prevention design. As skin cancer incidence continues to climb in the United States and worldwide, and as climate patterns extend warm-weather exposure seasons in many regions, the value of fine-grained, context-aware surveillance will only grow. The sunburn on a beach and the sunburn on a job site may look identical on the skin, but preventing them requires understanding them as the distinct events they are, and this study takes a substantial step toward that understanding.

Subject of Research: Sociodemographic patterns of sunburn contexts among U.S. adults based on NHIS 2024 data

Article Title: Sociodemographic patterns of specific sunburn contexts among U.S. adults reporting sunburn: analysis of NHIS 2024

Article References: Schneiderman, M., & Hartman, R. I. (2026). Sociodemographic patterns of specific sunburn contexts among U.S. adults reporting sunburn: analysis of NHIS 2024. Archives of Dermatological Research, 318(1), Article 500. https://doi.org/10.1007/s00403-026-04974-0

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04974-0

Keywords: sunburn, skin cancer, melanoma, NHIS, ultraviolet radiation, dermatology, epidemiology, sun protection, public health, sociodemographics, occupational exposure, prevention

The numbers behind dermatology’s competitiveness explain why such an experiment matters. According to data from the National Resident Matching Program cited by the authors, 2025 saw 993 applicants competing for just 524 available dermatology residency positions, a pool that included 676 U.S. MD seniors, 105 U.S. DO seniors, and 105 U.S. MD graduates. In a field this crowded, academic excellence and extracurricular achievement are only part of the equation. Mentorship and professional networking play vital roles in building a competitive application, yet these are precisely the resources that students from rural backgrounds most often lack. The result is a self-reinforcing cycle in which the specialty that most needs rural physicians recruits the fewest of them.

That cycle has measurable consequences. The authors point to research showing that only about 6 percent of dermatology applicants plan to practice in an underserved rural region after residency, and that those who do choose that path frequently come from rural backgrounds themselves. Parallel work on the broader physician workforce has documented a decline in rural medical students, a trend that threatens the geographic diversity of the profession and, with it, access to care for millions of Americans living far from major academic centers. In dermatology, where skin cancer prevention, early detection, and chronic disease management all depend on timely specialist access, the shortage of rural-trained and rural-minded dermatologists translates directly into delayed diagnoses and preventable morbidity.

Conference participation compounds the problem. Presenting research at scientific meetings is a recognized component of a competitive residency application, offering trainees the chance to share findings, receive feedback, and build the professional connections that shape future opportunities. But as the authors note, citing recent work on the financial burdens of conference attendance, the costs of registration, travel, and lodging can be prohibitive for many students. Those barriers fall hardest on trainees in rural states, particularly at institutions without academic dermatology programs or active dermatology societies that might otherwise subsidize attendance or provide local mentorship. While virtual scientific meetings became increasingly common after the COVID-19 pandemic and measurably expanded accessibility, no conference had been dedicated specifically to rural dermatology until the RADS initiative.

The Rural Access to Dermatology Society set out to close that gap using the most accessible platform available: the virtual symposium. The stated goal was twofold. First, to give students and residents with an interest in rural dermatology a national stage on which to present their research to peers and faculty. Second, to strip away the financial and geographic barriers that keep so many trainees from participating in academic life at all. The organizing model was lean and social-media driven. A call for abstracts was posted to the RADS social media accounts and amplified by partner organizations, most notably the Dermatology Interest Group Association, a national network of student dermatology interest groups.

The response was striking for a first-time, single-topic virtual meeting. The society received 76 abstract submissions, of which 15 were selected for presentation after review by RADS board members. Selection criteria emphasized relevance to rural dermatology, scientific merit, and overall quality. Recruitment of attendees relied on posted flyers and on the promotional reach of RADS faculty within the Association of Professors of Dermatology, a national organization of academic dermatologists whose members distributed the call through their own networks. The final registration count of 108 participants spanning 32 states suggests that the demand for a rural-focused dermatology forum was real and previously unmet, drawing participants from far beyond the rural states that inspired the initiative.

The scientific program itself was structured to serve the audience on both professional and practical levels. Two keynote speakers opened the symposium with rural-focused presentations, one addressing the implementation of teledermatology, the technology-enabled remote diagnosis and management of skin disease that has become a cornerstone of rural care delivery, and the other offering a pathologist’s perspective on improving skin biopsy techniques, a topic with direct implications for diagnostic accuracy in settings where specimens travel long distances to reach a laboratory. A resident panel followed, giving attendees the opportunity to ask candid questions about what it takes to pursue a career in rural dermatology, from application strategy to life in practice outside major metropolitan centers.

The fifteen student and resident presentations reflected a surprising breadth of research approaches for such a young meeting. Survey and observational studies accounted for 40 percent of the talks, database and geospatial analyses for 26.6 percent, literature reviews for 20 percent, and conceptual or pilot frameworks for the remaining 13.3 percent. Geospatial analysis in particular is a methodologically important tool in rural health research, mapping where dermatologists practice, where patients travel for care, and where gaps in coverage are widest. Thematically, the presentations clustered into five major areas: access to dermatologic care and rural health equity, with five presentations; skin cancer prevention, education, and community outreach, also with five; rural workforce and systems innovation, with three; vulnerable and occupational populations, with two; and disease-specific outcomes research, with two.

That thematic distribution mirrors the clinical realities of rural dermatology. Skin cancer prevention and early detection remain the specialty’s most visible public health priorities in rural regions, where agricultural and outdoor occupational exposure drives elevated ultraviolet radiation risk and where dermatologists are scarce. Workforce and systems research addresses the structural question of how care can be organized, through teledermatology, task-shifting, and regional referral networks, when the specialist workforce itself is thin. Studies of vulnerable and occupational populations highlight groups, from farmworkers to remote community residents, whose skin health needs are compounded by distance, cost, and occupational exposure. Taken together, the presented work demonstrates that meaningful rural dermatology research is already being produced by trainees, often at institutions with no academic dermatology department to support it.

The authors frame the 2025 symposium as a proof of concept rather than a finished model. Future iterations will incorporate participant feedback and, importantly, will begin to assess mentorship and collaboration outcomes, moving beyond attendance metrics to evaluate whether virtual meetings actually generate the professional relationships that sustain rural research careers. If those outcomes bear out, the model could extend well beyond dermatology, offering rural-focused trainees in other specialties an accessible route into academic life. What began as a workaround for the barriers of traditional conferencing may end up reshaping who gets to participate in medical science, and ultimately, who returns to care for the communities that need them most.

Subject of Research: A virtual research symposium expanding access and education in rural dermatology for medical students and residents.

Article Title: Expanding access and education: the Rural Access to Dermatology Society (RADS) Virtual Symposium showcasing student research in rural dermatology

Article References: Salmen, N. L., & Logue, M. E. (2026). Expanding access and education: the Rural Access to Dermatology Society (RADS) Virtual Symposium showcasing student research in rural dermatology. Archives of Dermatological Research, 318(1), Article 461. https://doi.org/10.1007/s00403-026-04959-z

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04959-z

Keywords: rural dermatology, virtual symposium, medical education, health equity, teledermatology, skin cancer prevention, rural workforce, residency match, student research, conference accessibility, Expanding, access